Abstract: Disclosed are an organometallic compound represented by Chemical Formula 1, and an organic light-emitting diode containing the same.

Abstract: An organometallic compound represented by Chemical Formula 1, and an organic light-emitting diode containing the same. In the Chemical Formula 1, Z represents one of O (oxygen), S (sulfur) or Se (selenium), m is 1 or 2, n is an integer from 0 to 2, and X Y is a bidentate ligand.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Abstract: Disclosed are an organometallic compound used as a phosphorescent dopant material of a light-emitting layer of an organic light-emitting diode, and the organic light-emitting diode containing the organometallic compound. The organometallic compound is represented by Ir(LA)m(LB)n, where LA is a ligand having a structure represented by Chemical Formula 2, and LB is a bidentate ligand.

Abstract: Disclosed are an organometallic compound used as a phosphorescent dopant material of a light-emitting layer of an organic light-emitting diode, and an organic light-emitting diode containing the same. The organometallic compound is represented by Ir(LA)m(LB)n. An organic light-emitting diode includes a first electrode; a second electrode facing the first electrode; and an organic layer disposed between the first electrode and the second electrode. The organic layer includes a light-emitting layer that contains the organometallic compound disclosed herein.

Abstract: A base station is provided.

Abstract: Provided is an apparatus for diagnosis and prediction of a severe accident in a nuclear power plant. The apparatus comprises a classification unit configured to derive a plurality of scenarios for diagnosis and prediction of the severe accident in the nuclear power plant; a strorage medium storing instructions for executing a method for diagnosis and prediction of the severe accident in the nuclear power plant using a learning model trained by a training database including training input variables for the plurality of scenarios and severe accident diagnosis and prediction information corresponding to the training input variables; and a processor configured to obtain diagnostic input variables for the diagnosis and prediction of the severe accident in the nuclear power plant, input the diagnostic input variables into the learning model to check the severe accident diagnosis and prediction information, and output the checked severe accident diagnosis and prediction information.

Abstract: The present disclosure relates to a plurality of organic electroluminescent materials comprising at least one first compound and at least one second compound, and an organic electroluminescent device comprising the same. By comprising a specific combination of compounds, in which the first compound is represented by formula 1 and the second compound is represented by formula 2, it is possible to provide an organic electroluminescent device having improved lifetime properties.

Abstract: A highly integrated multi-channel optical module is provided. The optical module includes an optical source device mounted on a substrate by an optical source mount unit, a waveguide mounted on the substrate by a waveguide mount unit, a lens mount unit disposed between the optical source device and the waveguide and mounted on the substrate, and a lens unit fixed to the lens mount unit by an adhesive cured by ultraviolet (UV) parallel light, wherein a light path of the UV parallel light is formed in the lens mount unit by a reflector attached on a side surface of the lens mount unit, and the UV parallel light moves along the light path and cures the adhesive coated on an upper portion of the lens mount unit facing a lower end portion of the lens unit.

Abstract: The present disclosure relates to organic electroluminescent devices. The organic electroluminescent device according to the present disclosure exhibits improved lifespan characteristics and progressive driving voltage by including at least one deuterated compound(s).

Abstract: Embodiments of the disclosure relate to articles and transistor structures and methods of preparation and use thereof, including a substrate and an amorphous oxide film overlaying at least a portion of the substrate, where the amorphous oxide film includes a first oxide and a second oxide. The first oxide can include zirconium oxide (ZrO2), hafnium oxide (HfO2) or a combination thereof, the second oxide can include silicon dioxide (SiO2), aluminum oxide (Al2O3), nitric oxide (NO) or combinations thereof. The amorphous oxide film can conformal and have a porosity of less than about 1% and may have a dielectric constant (k) of about 8 to about 28.

Abstract: A display driver integrated circuit, System-On-Chip, and display system including the System-On-Chip are provided.

Abstract: The present disclosure relates to an organic electroluminescent compound, a plurality of host materials, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound according to the present disclosure or by comprising a specific combination of compounds according to the present disclosure as a plurality of host materials, it is possible to produce an organic electroluminescent device having improved luminous efficiency, and/or lifetime properties compared to the conventional organic electroluminescent devices.

Abstract: An embodiment luggage gap cover device for a rear seat of a vehicle is provided. The rear seat includes an interlocking frame connecting a seatback of the rear seat to a seat cushion for a dive operation, and the luggage gap cover device includes a foldable cover mat on a rear surface of the seatback configured to cover a gap between the seatback and a floor plate of a luggage compartment and a support protrusion on the interlocking frame, the support protrusion being configured to push and support the cover mat in a direction of covering the gap between the seatback and the floor plate.

Abstract: A test device includes a main board. First and second device under test (DUT) boards are disposed on the main board. First and second semiconductor devices are mounted on the first and second DUT boards, respectively. The first and second semiconductor devices are DUTs. First and second connectors are respectively disposed at a first end and a second end of the first DUT board. The first and second connectors are spaced apart from each other and respectively transmit first and second signals. The first signal forms a first electrical path along which the first signal is input to the first DUT board via the first connector. The second signal forms a second electrical path along which the second signal is output from the first DUT board and input to the second DUT board via the second connector.

Abstract: Devices and methods are described for a contrast tray and framing devices for use with imagers. Some embodiments describe a contrast tray for use with an imager comprising one or more light diffusing layers configured to shift at least some of an imaging light and one or more light filtering layers configured to filter out at least some of the imaging light. Light diffusing and light filtering layers can be further configured to upconvert at least some of the diffused and/or non-filtered light. Contrast trays can be used to improve imaging of gels such as PAGE gels when using a green or blue-green light. Other embodiments of the disclosure describe a framing device that provides better illumination and lower background fluorescence for fluorescent gels, such as nucleic acid gels.

Abstract: An instrument for processing and/or measuring a biological process comprises a plurality of filter assemblies configured to be interchangeably located along at least one of the optical paths. The plurality of filter components includes a first filter assembly characterized by a first optical power and a first filter having a first filter function, the first filter function characterized by at least one of a first low-pass wavelength or a first high-pass wavelength. The second filter assembly is characterized by a second optical power and a second filter having a second filter function, the second filter function comprising at least one of a second low-pass wavelength that is different than the first low-pass wavelength or a second high-pass wavelength that is different than the first high-pass wavelength.

Abstract: Provided is a method for manufacturing a photomask. The method comprises providing a pre-photomask, the pre-photomask including a first area, a second area configured to perform a first duty correction, and a third area configured to perform a second duty correction; forming a pre-photoresist pattern using the pre-photomask such that the pre-photoresist pattern has a stepped shape having at least three steps in a cross-sectional view of the pre-photoresist pattern; analyzing a profile of the pre-photoresist pattern in the cross-sectional view; and inserting an auxiliary pattern into at least one of the first to third areas, based on a result of the analyzing of the profile of the pre-photoresist pattern.

Abstract: The present disclosure relates to managing a document to be cleaned, includes processing a request, in response to the request to store document data of a first document in a database, based on at least one of whether the first document is duplicate or whether substantive contents of the first document are a same in a relationship with a second document pre-stored in the database, whether the first document is duplicate may be determined by comparing a unique identification value and version information of the first document with a unique identification value and version information of the second document, and whether substantive contents of the first document are the same may be determined by comparing hash data of the first document with hash data of the second document.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.